[Vaccination in Workplace and Compensation for Adverse Events]

Area of Science:

• Public Health
• Immunology
• Law

Background:

• Rapid development and emergency use approval of SARS-CoV-2 vaccines under the Pharmaceutical Act.
• Mass vaccination campaigns in Japan targeted healthcare workers and the elderly.
• COVID-19 pathophysiology and post-vaccination health damage reports were reviewed.

Purpose of the Study:

• To examine legal frameworks surrounding COVID-19 vaccination in Japan.
• To analyze compensation programs and remedial measures for vaccine-related health damages.
• To propose legislative improvements for future pandemic preparedness.

Main Methods:

• Overview of COVID-19 pathophysiology.
• Review of literature on fatal outcomes and compensation programs.
• Analysis of relevant Japanese legislation including the Immunization Act, Civil Code, and State Redress Act.

Main Results:

• The Immunization Act was amended to allow government indemnity agreements with pharmaceutical companies for vaccine-related damages.
• Employers may seek reimbursement for damages paid to third parties under the Civil Code and State Redress Act.
• Current legislation does not exempt healthcare and occupational health staff from potential lawsuits and liability.

Conclusions:

• Legislative reform is needed to address liability and compensation for emergency vaccinations.
• Careful contractual agreements are essential for organizations involved in mass vaccinations.
• Proactive legal and contractual measures are crucial for managing future infectious disease outbreaks.